Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita. Blood Adv. 2018 06 12; 2(11):1243-1249.

View in: PubMed